Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity

Cliona Stack, Shari Jainuddin, Ceyhan Elipenahli, Meri Gerges, Natalia Starkova, Anatoly A. Starkov, Mariona Jové, Manuel Portero-Otin, Nathalie Launay, Aurora Pujol, Navneet Ammal Kaidery, Bobby Thomas, Davide Tampellini, M. Flint Beal, Magali Dumont

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Methylene blue (MB, methylthioninium chloride) is a phenothiazine that crosses the blood brain barrier and acts as a redox cycler. Among its beneficial properties are its abilities to act as an antioxidant, to reduce tau protein aggregation and to improve energy metabolism. These actions are of particular interest for the treatment of neurodegenerative diseases with tau protein aggregates known as tauopathies. The present study examined the effects of MB in the P301S mouse model of tauopathy. Both 4 mg/kg MB (low dose) and 40 mg/kg MB (high dose) were administered in the diet ad libitum from 1 to 10months of age.Weassessed behavior, tau pathology, oxidative damage, inflammation and numbers of mitochondria. MB improved the behavioral abnormalities and reduced tau pathology, inflammation and oxidative damage in the P301S mice. These beneficial effects were associated with increased expression of genes regulated by NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE), which play an important role in antioxidant defenses, preventing protein aggregation, and reducing inflammation. The activation of Nrf2/ARE genes is neuroprotective in other transgenic mouse models of neurodegenerative diseases and it appears to be an important mediator of the neuroprotective effects of MB in P301S mice. Moreover, we used Nrf2 knock out fibroblasts to show that the upregulation of Nrf2/ARE genes by MB is Nrf2 dependent and not due to secondary effects of the compound. These findings provide further evidence that MB has important neuroprotective effects that may be beneficial in the treatment of human neurodegenerative diseases with tau pathology.

Original languageEnglish (US)
Article numberddu080
Pages (from-to)3716-3732
Number of pages17
JournalHuman Molecular Genetics
Volume23
Issue number14
DOIs
StatePublished - Jul 2014

Fingerprint

NF-E2-Related Factor 2
Antioxidant Response Elements
Methylene Blue
Up-Regulation
Neurodegenerative Diseases
Tauopathies
tau Proteins
Genes
Neuroprotective Agents
Pathology
Inflammation
Antioxidants
Aptitude
Blood-Brain Barrier
Energy Metabolism
Transgenic Mice
Oxidation-Reduction
Mitochondria
Fibroblasts
Diet

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Stack, C., Jainuddin, S., Elipenahli, C., Gerges, M., Starkova, N., Starkov, A. A., ... Dumont, M. (2014). Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity. Human Molecular Genetics, 23(14), 3716-3732. [ddu080]. https://doi.org/10.1093/hmg/ddu080

Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity. / Stack, Cliona; Jainuddin, Shari; Elipenahli, Ceyhan; Gerges, Meri; Starkova, Natalia; Starkov, Anatoly A.; Jové, Mariona; Portero-Otin, Manuel; Launay, Nathalie; Pujol, Aurora; Kaidery, Navneet Ammal; Thomas, Bobby; Tampellini, Davide; Flint Beal, M.; Dumont, Magali.

In: Human Molecular Genetics, Vol. 23, No. 14, ddu080, 07.2014, p. 3716-3732.

Research output: Contribution to journalArticle

Stack, C, Jainuddin, S, Elipenahli, C, Gerges, M, Starkova, N, Starkov, AA, Jové, M, Portero-Otin, M, Launay, N, Pujol, A, Kaidery, NA, Thomas, B, Tampellini, D, Flint Beal, M & Dumont, M 2014, 'Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity', Human Molecular Genetics, vol. 23, no. 14, ddu080, pp. 3716-3732. https://doi.org/10.1093/hmg/ddu080
Stack C, Jainuddin S, Elipenahli C, Gerges M, Starkova N, Starkov AA et al. Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity. Human Molecular Genetics. 2014 Jul;23(14):3716-3732. ddu080. https://doi.org/10.1093/hmg/ddu080
Stack, Cliona ; Jainuddin, Shari ; Elipenahli, Ceyhan ; Gerges, Meri ; Starkova, Natalia ; Starkov, Anatoly A. ; Jové, Mariona ; Portero-Otin, Manuel ; Launay, Nathalie ; Pujol, Aurora ; Kaidery, Navneet Ammal ; Thomas, Bobby ; Tampellini, Davide ; Flint Beal, M. ; Dumont, Magali. / Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity. In: Human Molecular Genetics. 2014 ; Vol. 23, No. 14. pp. 3716-3732.
@article{6651a4de9b0947c28589fa66c12667ba,
title = "Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity",
abstract = "Methylene blue (MB, methylthioninium chloride) is a phenothiazine that crosses the blood brain barrier and acts as a redox cycler. Among its beneficial properties are its abilities to act as an antioxidant, to reduce tau protein aggregation and to improve energy metabolism. These actions are of particular interest for the treatment of neurodegenerative diseases with tau protein aggregates known as tauopathies. The present study examined the effects of MB in the P301S mouse model of tauopathy. Both 4 mg/kg MB (low dose) and 40 mg/kg MB (high dose) were administered in the diet ad libitum from 1 to 10months of age.Weassessed behavior, tau pathology, oxidative damage, inflammation and numbers of mitochondria. MB improved the behavioral abnormalities and reduced tau pathology, inflammation and oxidative damage in the P301S mice. These beneficial effects were associated with increased expression of genes regulated by NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE), which play an important role in antioxidant defenses, preventing protein aggregation, and reducing inflammation. The activation of Nrf2/ARE genes is neuroprotective in other transgenic mouse models of neurodegenerative diseases and it appears to be an important mediator of the neuroprotective effects of MB in P301S mice. Moreover, we used Nrf2 knock out fibroblasts to show that the upregulation of Nrf2/ARE genes by MB is Nrf2 dependent and not due to secondary effects of the compound. These findings provide further evidence that MB has important neuroprotective effects that may be beneficial in the treatment of human neurodegenerative diseases with tau pathology.",
author = "Cliona Stack and Shari Jainuddin and Ceyhan Elipenahli and Meri Gerges and Natalia Starkova and Starkov, {Anatoly A.} and Mariona Jov{\'e} and Manuel Portero-Otin and Nathalie Launay and Aurora Pujol and Kaidery, {Navneet Ammal} and Bobby Thomas and Davide Tampellini and {Flint Beal}, M. and Magali Dumont",
year = "2014",
month = "7",
doi = "10.1093/hmg/ddu080",
language = "English (US)",
volume = "23",
pages = "3716--3732",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "14",

}

TY - JOUR

T1 - Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity

AU - Stack, Cliona

AU - Jainuddin, Shari

AU - Elipenahli, Ceyhan

AU - Gerges, Meri

AU - Starkova, Natalia

AU - Starkov, Anatoly A.

AU - Jové, Mariona

AU - Portero-Otin, Manuel

AU - Launay, Nathalie

AU - Pujol, Aurora

AU - Kaidery, Navneet Ammal

AU - Thomas, Bobby

AU - Tampellini, Davide

AU - Flint Beal, M.

AU - Dumont, Magali

PY - 2014/7

Y1 - 2014/7

N2 - Methylene blue (MB, methylthioninium chloride) is a phenothiazine that crosses the blood brain barrier and acts as a redox cycler. Among its beneficial properties are its abilities to act as an antioxidant, to reduce tau protein aggregation and to improve energy metabolism. These actions are of particular interest for the treatment of neurodegenerative diseases with tau protein aggregates known as tauopathies. The present study examined the effects of MB in the P301S mouse model of tauopathy. Both 4 mg/kg MB (low dose) and 40 mg/kg MB (high dose) were administered in the diet ad libitum from 1 to 10months of age.Weassessed behavior, tau pathology, oxidative damage, inflammation and numbers of mitochondria. MB improved the behavioral abnormalities and reduced tau pathology, inflammation and oxidative damage in the P301S mice. These beneficial effects were associated with increased expression of genes regulated by NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE), which play an important role in antioxidant defenses, preventing protein aggregation, and reducing inflammation. The activation of Nrf2/ARE genes is neuroprotective in other transgenic mouse models of neurodegenerative diseases and it appears to be an important mediator of the neuroprotective effects of MB in P301S mice. Moreover, we used Nrf2 knock out fibroblasts to show that the upregulation of Nrf2/ARE genes by MB is Nrf2 dependent and not due to secondary effects of the compound. These findings provide further evidence that MB has important neuroprotective effects that may be beneficial in the treatment of human neurodegenerative diseases with tau pathology.

AB - Methylene blue (MB, methylthioninium chloride) is a phenothiazine that crosses the blood brain barrier and acts as a redox cycler. Among its beneficial properties are its abilities to act as an antioxidant, to reduce tau protein aggregation and to improve energy metabolism. These actions are of particular interest for the treatment of neurodegenerative diseases with tau protein aggregates known as tauopathies. The present study examined the effects of MB in the P301S mouse model of tauopathy. Both 4 mg/kg MB (low dose) and 40 mg/kg MB (high dose) were administered in the diet ad libitum from 1 to 10months of age.Weassessed behavior, tau pathology, oxidative damage, inflammation and numbers of mitochondria. MB improved the behavioral abnormalities and reduced tau pathology, inflammation and oxidative damage in the P301S mice. These beneficial effects were associated with increased expression of genes regulated by NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE), which play an important role in antioxidant defenses, preventing protein aggregation, and reducing inflammation. The activation of Nrf2/ARE genes is neuroprotective in other transgenic mouse models of neurodegenerative diseases and it appears to be an important mediator of the neuroprotective effects of MB in P301S mice. Moreover, we used Nrf2 knock out fibroblasts to show that the upregulation of Nrf2/ARE genes by MB is Nrf2 dependent and not due to secondary effects of the compound. These findings provide further evidence that MB has important neuroprotective effects that may be beneficial in the treatment of human neurodegenerative diseases with tau pathology.

UR - http://www.scopus.com/inward/record.url?scp=84902953435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902953435&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddu080

DO - 10.1093/hmg/ddu080

M3 - Article

C2 - 24556215

AN - SCOPUS:84902953435

VL - 23

SP - 3716

EP - 3732

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 14

M1 - ddu080

ER -